Brief: Twist Bioscience Reports First Quarter 2024 Financial Results

Twist Bioscience

02/02/2024 13:44

Feb 2 (Reuters) - Twist Bioscience Corp  TWST.O :
    * TWIST BIOSCIENCE REPORTS FISCAL FIRST QUARTER 2024
FINANCIAL
RESULTS
    * : INCREASED FY 2024 REVENUE GUIDANCE TO $288M TO $293M;
INCREASED FY 2024 GROSS MARGIN GUIDANCE TO 40% TO 41%
    * : SEES  Q2 OF FISCAL YEAR 2024, TOTAL REVENUE OF
APPROXIMATELY
$70 MILLION TO $71 MILLION
    * : AS OF DEC 31, 2023, CO HAD $311.1 MILLION IN CASH, CASH
EQUIVALENTS AND SHORT-TERM INVESTMENTS
    * FY2024 REVENUE VIEW $289.8 MILLION -- LSEG IBES DATA
    * Q2 REVENUE VIEW $70.1 MILLION -- LSEG IBES DATA
    * : SEES GROSS MARGIN IS EXPECTED TO BE APPROXIMATELY 40% TO
41%
FOR FISCAL 2024
    * : SEES  Q2 GROSS MARGIN OF 39%

Source text for Eikon:  ID:nBw5jd1KGa 
Further company coverage:  TWST.O 

 ((Reuters.Briefs@thomsonreuters.com;))